Personnel

OSI Pharmaceuticals announces three additions to its 2006 board of directors slate

Published in Drug Week, May 26th, 2006

OSI Pharmaceuticals, Inc. (OSIP) announced that the nominating committee of its board of directors has set the slate of nominees for election at the annual meeting of its stockholders. The nominating committee has recommended that stockholders elect David Niemiec, Joseph "Skip" Klein III and Santo "Sandy" Costa in addition to the existing ten directors.

Costa is currently of counsel at the law firm Maupin Taylor, P.A. Costa previously held several positions with Quintiles Transnational Corp., including president and chief operating officer and vice-chairman. Prior to joining Quintiles, Costa spent 23 years in the pharmaceutical industry, most recently as senior vice...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2006-05-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry